Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells

Gynecologic Oncology

Volumn 85, Issue 3, 2002, Pages 451-458

  Tanyi, Janos L ^a   Lapushin, Ruth ^a   Eder, Astrid ^a   Auersperg, Nelly ^b   Tabassam, Fazal H ^a   Roth, Jack A ^a   Gu, Jian ^a   Fang, Binglian ^a   Mills, Gordon B ^a   Wolf, Judith ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Ovarian cancer; Promoter; Tissue specific; Tumor specific

Indexed keywords

EPITHELIUM SPECIFIC ETS TRANSCRIPTION FACTOR; GREEN FLUORESCENT PROTEIN; LUCIFERASE; OVARY SPECIFIC PROMOTER 1; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS T ANTIGEN;

ANIMAL CELL; ARTICLE; CELL LINEAGE; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER PARENCHYMA; MESOTHELIUM; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; TUMOR CELL LINE;

EID: 0036083729     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6644     Document Type: Article

References (31)

1. Mechanism based target identification and drug discovery in cancer research
2. Use of a tissue-specific promoter for targeted expression of the herpes simplex virus thymidine kinase gene in cervical carcinoma cells
3. Isolation, properties and complete amino acid sequence of human secretory leukocyte proteinase inhibitor, a potent inhibitor of leukocyte elastase
4. Retroviral-like sequences specifically expressed in the rat ovary detect genetic differences between normal and transformed rat ovarian surface epithelial cells
5. Ovarian epithelial cell lineage-specific gene expression using the promoter of a retrovirus-like element
6. The epithelium-specific Ets transcription factor ESX is associated with mammary gland development and involution
7. ESX: A structurally unique Ets overexpressed early during human breast tumorigenesis
8. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancer
9. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells
10. Specific association of human telomerase activity with immortal cells and cancer
11. An ovarian adenocarcinoma line derived from SV40/E-cadherin transfected normal human ovarian surface epithelium
12. Enhanced c-erb-2/ncu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A
13. Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells
14. Modification of non-conservative double-strand break (DSB) rejoining activity after the introduction of cisplatin resistance in human tumour cells
15. Epithelial ovarian cancer
16. Liver-associated toxicity of the HSV-TK/GCV approach and adenoviral vectors
17. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo
18. Ultrastructural localization of antileukoprotease in serous cells of bronchial glands and in non-ciliated bronchiolar epithelial cells of human lung
19. Tissue distribution of antileukoproteinase and lysozyme in humans
20. Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold labeling technique using monoclonal antibodies
21. The Ets family of transcription factors
22. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts
23. A telomeric sequences in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
24. Identification of a novel transcription factor binding element involved in the regulation by differentiation of the human telomerase (hTERT) promoter
25. Frequent amplification of the telomerase reverse transcriptase gene in human tumors
26. Telomerase activity in human ovarian carcinoma
27. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells
28. Estrogen activates telomerase
29. The use of L-plastin promoter for adenoviral mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines
30. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cell